Search

Search Constraints

You searched for: Author/Creator Lokhorst, Henk M.

Search Results

2. CD38-targeting antibodies in multiple myeloma: mechanisms of action and clinical experience. (4th March 2018)

3. Experience with outcomes research into the real-world effectiveness of novel therapies in Dutch daily practice from the context of conditional reimbursement. Issue 2 (February 2015)

4. High‐Parameter Mass Cytometry Evaluation of Relapsed/Refractory Multiple Myeloma Patients Treated with Daratumumab Demonstrates Immune Modulation as a Novel Mechanism of Action. Issue 3 (11th December 2018)

6. Impact of Fc gamma receptor polymorphisms on efficacy and safety of daratumumab in relapsed/refractory multiple myeloma. (7th February 2018)

7. Impact of ocular graft‐versus‐host disease on visual quality of life in patients after allogeneic stem cell transplantation: questionnaire study. (22nd April 2013)

9. Outcome of allogeneic transplantation in newly diagnosed and relapsed/refractory multiple myeloma: long‐term follow‐up in a single institution. (3rd May 2016)

10. Potential prognostic implications of whole‐body bone marrow MRI in diffuse large B‐cell lymphoma patients with a negative blind bone marrow biopsy. Issue 6 (14th November 2013)